STEPUPIORS team member Dr Suzana Stojanović-Rundić presented project aims during the 59th Cancerology week, the National annual oncology congress, held in Belgrade, Serbia, in the period November 23-26, 2022.
During her presentation, Dr Stojanović-Rundić outlined the significance of molecular profiling of the response to neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer. The STEPUPIORS project will focus on a more precise selection of patients who might be candidates for a less invasive surgical approach or for enrollment in a “watch and wait” approach, which would increase their quality of life.
